Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Pounds

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Pharmacogenomics|September 13, 2013
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsXueyuan Cao, Amit K Mitra, Stanley Pounds, et al.
Cancer|June 1, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemiaHiroto Inaba, Harriet C Surprise, Stanley Pounds, et al.
The Journal of Clinical Investigation|September 8, 2022
Mutant Samd9l expression impairs hematopoiesis and induces bone marrow failure in miceSherif Abdelhamed, Melvin E Thomas, Tamara Westover, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2018
Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic LeukemiaHana Hakim, Ronald Dallas, Joshua Wolf, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2011
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemiaAmit K Mitra, Kristine R Crews, Stanley Pounds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy AugmentationAbdelrahman H Elsayed, Xueyuan Cao, Amit K Mitra, et al.
The Journal of Clinical Investigation|December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemiaJolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
NPJ Precision Oncology|October 2, 2024
Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumorsQuynh T Tran, Alex Breuer, Tong Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapyLeslie Mortland, Todd A Alonzo, Roland B Walter, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Pharmacogenomics|September 13, 2013
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsXueyuan Cao, Amit K Mitra, Stanley Pounds, et al.
Cancer|June 1, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemiaHiroto Inaba, Harriet C Surprise, Stanley Pounds, et al.
The Journal of Clinical Investigation|September 8, 2022
Mutant Samd9l expression impairs hematopoiesis and induces bone marrow failure in miceSherif Abdelhamed, Melvin E Thomas, Tamara Westover, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2018
Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic LeukemiaHana Hakim, Ronald Dallas, Joshua Wolf, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2011
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemiaAmit K Mitra, Kristine R Crews, Stanley Pounds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy AugmentationAbdelrahman H Elsayed, Xueyuan Cao, Amit K Mitra, et al.
The Journal of Clinical Investigation|December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemiaJolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
NPJ Precision Oncology|October 2, 2024
Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumorsQuynh T Tran, Alex Breuer, Tong Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapyLeslie Mortland, Todd A Alonzo, Roland B Walter, et al.
Pageof 13